SLAMF7 has been reported to promote the induction and activation of NK cell cytotoxicity [15, 16], and enhance macrophage-mediated phagocytosis of tumor cells [13, 17], recognized as a critical immunoregulatory receptor involved in antitumor immunity [18, 19]. Here, SLAMF7 is linked to neoplasm.